Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 24;19(1):172.
doi: 10.1186/s12877-019-1174-3.

Prevalence of dementia diagnoses not otherwise specified in eight European countries: a cross-sectional cohort study

Connie Lethin  1   2 , Ingalill Rahm Hallberg  3 , Anna Renom Guiteras  4 , Hilde Verbeek  5 , Kai Saks  6 , Minna Stolt  7 , Adelaida Zabalegui  8 , Maria Soto-Martin  9 , Christer Nilsson  10
Affiliations

Prevalence of dementia diagnoses not otherwise specified in eight European countries: a cross-sectional cohort study

Connie Lethin et al. BMC Geriatr. .

Abstract

Background: Dementia is a syndrome, with a wide range of symptoms. It is important to have a timely diagnosis during the disease course to reduce the risk of medication errors, enable future care planning for the patient and their relatives thereby optimizing quality of life (QoL). For this reason, it is important to avoid a diagnosis of dementia not otherwise specified (DNOS) and instead obtain a diagnosis that reflects the underlying pathology. The aim of this study was to investigate the prevalence and associated factors of DNOS in persons with dementia living at home or in a nursing home.

Methods: This is a cross-sectional cohort study performed in eight European countries. Persons with dementia aged ≥65 years living at home (n = 1223) or in a nursing home (n = 790) were included. Data were collected through personal interviews with questionnaires based on standardised instruments. Specific factors investigated were sociodemographic factors, cognitive function, and mental health, physical health, QoL, resource utilization and medication. Bivariate and backward stepwise multivariate regression analyses were performed.

Results: The prevalence of DNOS in the eight participating European countries was 16% (range 1-30%) in persons living at home and 21% (range 1-43%) in persons living in a nursing home. These people are more often older compared to those with a specific dementia diagnosis. In both persons living at home and persons living in a nursing home, DNOS was associated with more severe neuropsychiatric symptoms and less use of anti-dementia medication. In addition, persons with DNOS living at home had more symptoms of depression and less use of antidepressant medication.

Conclusions: The prevalence of DNOS diagnosis is common and seems to vary between European countries. People with DNOS are more often older with more severe neuropsychiatric symptoms and receive fewer anti-dementia medication, anxiolytics and antidepressants. This would support the suggestion that a proper and specific diagnosis of dementia could help the management of their disease.

Keywords: Dementia; Diagnosis; Geriatrics; Home care; Neurocognitive disorders; Nursing homes; Ordinary housing; Regression analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Goodman RA, Lochner KA, Thambisetty M, Wingo TS, Posner SF, Ling SM. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013. Alzheimers Dement. 2017;13(1):28–37. doi: 10.1016/j.jalz.2016.04.002. - DOI - PMC - PubMed
    1. Prince M, Bryce R, Ferri C. The benefits of early diagnosis and intervention. 2011. p. 72.
    1. Standridge JB. Pharmacotherapeutic approaches to the prevention of Alzheimer’s disease. Am J Geriatr Pharmacother. 2004;2(2):119–132. doi: 10.1016/S1543-5946(04)90017-7. - DOI - PubMed
    1. Emre M, Tsolaki M, Bonuccelli U, Destee A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladstrom A, Jones R. Memantine for patients with Parkinson’s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9(10):969–977. doi: 10.1016/S1474-4422(10)70194-0. - DOI - PubMed
    1. Ali TB, Schleret TR, Reilly BM, Chen WY, Abagyan R. Adverse effects of cholinesterase inhibitors in dementia, according to the pharmacovigilance databases of the United-States and Canada. PLoS One. 2015;10(12):e0144337. doi: 10.1371/journal.pone.0144337. - DOI - PMC - PubMed

Publication types